United States Senate Special Committee on Aging
Hearings

The Right Medicine? Examining the Breaux-Frist Prescription for Saving Medicare

February 8, 2000

The Committee will examine both elements of S.1895: its overall restructuring plan, and its provisions for providing prescription drug coverage.
Date: February 8, 2000
Time: 9:30 a.m.
562 Dirksen Senate Office Building

Statements of Committee Members

Witness Testimony Opening Remarks: Senator Bill Frist (R-TN, no prepared statement provided

Panel I - General Reform
  1. David Walker, Comptroller General, General Accounting Office, Washington, DC

  2. Gail Wilensky, Ph.D., John M. Olin Senior Fellow, Project Hope, Bethesda, Maryland

  3. Stephen L. Goeser, Administrator/CEO, Myrtue Memorial Hospital, Harlan, Iowa

Panel II - Prescription Drugs

  1. Beatrice Braun, M.D., Board of Directors, AARP, Washington, DC

  2. Mitchell E. Daniels, Jr., Senior Vice President of Corporate Strategy and Policy, Eli Lilly and Company, Indianapolis, Indiana

  3. Deborah Steelman, President, Steelman Health Strategies, Washington, DC

Hearing Publications
  • Committee on Aging Print: 106-22